An FDA advisory panel has voted to recommend six popular peptides, including BPC-157, TB-500, and KPV, for compounding by licensed pharmacies. This decision could significantly expand access to these substances for millions of individuals.
FDA Panel Recommends Broader Access to Key Peptides for Compounding
FDAPeptidesPharmaceuticalsRegulationHealthcare
